Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease

Cardiovascular disease (CVD) in Mucopolysaccharidosis Type IVA (Morquio A), signified by valvular disease and cardiac hypertrophy, is the second leading cause of death and remains untouched by current therapies. Enzyme replacement therapy (ERT) is the gold-standard treatment for MPS disorders includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Montavon, Brittany, Winter, Linda E., Gan, Qi, Arasteh, Amirhossein, Montaño, Adriana M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127057/
https://www.ncbi.nlm.nih.gov/pubmed/35620518
http://dx.doi.org/10.3389/fcvm.2022.829111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127057/
https://www.ncbi.nlm.nih.gov/pubmed/35620518
http://dx.doi.org/10.3389/fcvm.2022.829111

Ejemplares similares